Cary Shiwarski

NPI 1134495955ActiveIndividual· Internal Medicine, Nephrology· Pittsburgh, PA

Internal Medicine, Nephrology in Pittsburgh, Pennsylvania, trained at University of Pittsburgh School of Medicine (class of 2012). 81 Medicare patients in 2024, $12,253 paid; nearly all of their 101 Part D prescriptions were generic (92%). Genzyme Corporation reported $73.87 in payments in 2025, mostly food and beverage.

Overview

NPI	1134495955
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Mar 26, 2012
Last updated in NPPES	Mar 25, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Nephrology Primary	207RN0300X	MD457150	PA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Nephrology (PA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	81
Services billed	183 across 10 procedure codes
Paid by Medicare	$12,253

Part D prescriptions in 2024

Prescriptions (claims)	101 · 228 30-day fills
Patients	21
Total drug cost	$16,546
Generic share	92% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Pittsburgh School of Medicine
Graduation year	2012
Medicare specialty	Nephrology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth